drugset / Trial / NCT02327741

Efficacy of Long Term Plavix Therapy Post Angioplasty

NCT02327741

RandomizedParallel-groupTriple-blindTreatment

Summary

1010 patients post stenting were enrolled to receive Plavix more than 12 months and less than that and rate of bleeding, complication and major cardiovascular adverse events ( MACE) were compared to evaluate safety and feasibility of long term Plavix therapy post stenting.

Timeline

Start
2012-10
Primary completion
2014-09
Completion
2014-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Clopidogrel Small molecule

Indications

No indication recorded.